633 970

Cited 27 times in

MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation

DC Field Value Language
dc.contributor.author김소영-
dc.contributor.author김주항-
dc.contributor.author선보경-
dc.contributor.author송재진-
dc.contributor.author오세은-
dc.contributor.author응구엔응옥호안-
dc.contributor.author최혜진-
dc.date.accessioned2014-12-20T16:21:43Z-
dc.date.available2014-12-20T16:21:43Z-
dc.date.issued2011-
dc.identifier.issn1021-335X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/92574-
dc.description.abstractThe tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to activate mitogen-activated protein kinases (MAPKs) depending on caspase and mammalian sterile 20-like kinase 1 activations. However, the upstream molecule of MAPKs has not yet been identified. The mitogen-activated protein kinase kinase 1 (MEKK1) and the apoptosis signal-regulating kinase 1 (ASK1) are considered to be possible candidates for the action of MAPKKKs induced by TRAIL and the possibility of reactive oxygen species involvement has also been investigated. We found that MEKK1/MEKK4 as opposed to ASK1, are responsible for TRAIL-induced c-Jun NH2-terminal kinase (JNK) or p38 activation, and that their catalytic activity is repressed by the caspase-8 inhibitor, suggesting that the caspase-8 activation induced by TRAIL is indispensible for MEKK activation. The 14-3-3 θ was also shown to interact with and to dissociate from MEKK1 by TRAIL treatment, thus implicating the 14-3-3 protein as a negative regulator of MEKK1 activation. Taken together, we show herein that the upstream molecule of the TRAIL-induced MAPK activation is MEKK, as opposed to ASK1, via the mediation of its signal through JNK/p38 in a caspase-8-dependent manner.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.relation.isPartOfONCOLOGY REPORTS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESH14-3-3 Proteins/metabolism-
dc.subject.MESHAntibodies/pharmacology-
dc.subject.MESHCell Line, Tumor-
dc.subject.MESHEnzyme Activation/drug effects-
dc.subject.MESHHumans-
dc.subject.MESHJNK Mitogen-Activated Protein Kinases/metabolism*-
dc.subject.MESHMAP Kinase Kinase 4/antagonists & inhibitors-
dc.subject.MESHMAP Kinase Kinase 4/genetics-
dc.subject.MESHMAP Kinase Kinase Kinase 1/antagonists & inhibitors-
dc.subject.MESHMAP Kinase Kinase Kinase 1/immunology-
dc.subject.MESHMAP Kinase Kinase Kinase 1/metabolism-
dc.subject.MESHMAP Kinase Kinase Kinase 1/physiology*-
dc.subject.MESHMAP Kinase Kinase Kinase 4/antagonists & inhibitors-
dc.subject.MESHMAP Kinase Kinase Kinase 4/immunology-
dc.subject.MESHMAP Kinase Kinase Kinase 4/metabolism-
dc.subject.MESHMAP Kinase Kinase Kinase 4/physiology*-
dc.subject.MESHPhosphorylation/drug effects-
dc.subject.MESHProtein Binding/drug effects-
dc.subject.MESHProtein Binding/physiology-
dc.subject.MESHRNA, Small Interfering/pharmacology-
dc.subject.MESHTNF-Related Apoptosis-Inducing Ligand/pharmacology*-
dc.subject.MESHp38 Mitogen-Activated Protein Kinases/metabolism*-
dc.titleMEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentYonsei Biomedical Research Center (연세의생명연구원)-
dc.contributor.googleauthorBo K Sun-
dc.contributor.googleauthorJoo-Hang Kim-
dc.contributor.googleauthorHoan N. Nguyen-
dc.contributor.googleauthorSeeun Oh-
dc.contributor.googleauthorSo Y. Kim-
dc.contributor.googleauthorHye J.-
dc.contributor.googleauthorHye J. Choi-
dc.contributor.googleauthorYong J. Lee-
dc.contributor.googleauthorJae J. Song-
dc.identifier.doi10.3892/or.2010.1079-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00945-
dc.contributor.localIdA01933-
dc.contributor.localIdA02378-
dc.contributor.localIdA02636-
dc.contributor.localIdA04219-
dc.contributor.localIdA00621-
dc.contributor.localIdA02056-
dc.relation.journalcodeJ02419-
dc.identifier.eissn1791-2431-
dc.identifier.pmid21152872-
dc.contributor.alternativeNameKim, So Young-
dc.contributor.alternativeNameKim, Joo Hang-
dc.contributor.alternativeNameSun, Bo Kyung-
dc.contributor.alternativeNameSong, Jae Jin-
dc.contributor.alternativeNameOh, Se Eun-
dc.contributor.alternativeNameNguyen, Hoan N.-
dc.contributor.alternativeNameChoi, Hye Jin-
dc.contributor.affiliatedAuthorKim, Joo Hang-
dc.contributor.affiliatedAuthorSun, Bo Kyung-
dc.contributor.affiliatedAuthorOh, Se Eun-
dc.contributor.affiliatedAuthorNguyen, Hoan N.-
dc.contributor.affiliatedAuthorChoi, Hye Jin-
dc.contributor.affiliatedAuthorKim, So Young-
dc.contributor.affiliatedAuthorSong, Jae Jin-
dc.rights.accessRightsfree-
dc.citation.volume25-
dc.citation.number2-
dc.citation.startPage537-
dc.citation.endPage544-
dc.identifier.bibliographicCitationONCOLOGY REPORTS, Vol.25(2) : 537-544, 2011-
dc.identifier.rimsid28639-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.